Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01262365 |
|---|---|
| Brief Title: | Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (EMBODY1) |
| First Submitted : | December 14, 2010 |
| First Submitted that Met QC Criteria : | December 15, 2010 |
| First Posted : | December 17, 2010 (Estimate) |
| Results First Submitted : | May 30, 2018 |
| Results First Submitted that Met QC Criteria : | June 4, 2018 |
| Results First Posted : | June 29, 2018 |
| Certification/Extension First Submitted : | January 12, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | January 12, 2016 |
| Certification/Extension First Posted : | February 5, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 31, 2018 |
| Last Update Posted : | September 28, 2018 |